Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 1Overweight 1Obesity 1

Interventions

Metformin 152Clomiphene 52Letrozole 41Inositol 35Folic Acid 18Progesterone 17Exercise 17Ethinyl Estradiol 13Estradiol 13Chorionic Gonadotropin 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Contraceptives, Oral 12cetrorelix 11Pioglitazone 10High-Intensity Interval Training 10Cholecalciferol 10Triptorelin Pamoate 9Tablets 9Spironolactone 9Menotropins 8Diet 8Vitamin D 7Thioctic Acid 7Surveys and Questionnaires 7Liraglutide 7Gonadotropins 7Acupuncture Therapy 7follitropin alfa 6drospirenone 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × Cyproterone × Clear all
NCT03151005 2023-12-04

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

Xinqiao Hospital of Chongqing

Phase 4 Completed
70 enrolled 11 charts
Other

Obesity, Polycystic Ovary Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡